Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancer

Gerasimos Aravantinos; Meletios A Dimopoulos; P Kosmidis; Dimitrios Bafaloukos; Christos Papadimitriou; Christos Kiamouris; N. Pavlidis; K. Sikiotis; Pavlos Papakostas; D. Skarlos

doi:10.1023/a:1008327412571

Related publications

Article1997

Ifosfamide and paclitaxel salvage chemotherapy for advanced epithelial ovarian cancer

Meletios A Dimopoulos, Christos Papadimitriou, C. Gennatas, T. Akrivos, George Vlahos, Zannis Voulgaris, E. Diacomanolis, P. Athanassiades, S. Mihalas

Article2003

Phase II study of docetaxel–vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer

Gerasimos Aravantinos, Dimitrios Bafaloukos, George Fountzilas, Christos Christodoulou, Christos Papadimitriou, N Pavlidis, Haralabos P. Kalofonos, Helen Gogas, P. Kosmidis, Meletios A Dimopoulos

Preprint2021

Pembrolizumab in Combination with Bevacizumab and Oral Cyclophosphamide in Heavily Pretreated Platinum-Resistant Ovarian Cancer

Αngeliki Andrikopoulou, Michalis Liontos, Efthymia Skafida, Konstantinos Koutsoukos, Kleoniki Apostolidou, Μαρία Καπαρέλου, Angeliki Rouvalis, Garyfallia Bletsa, Meletios A Dimopoulos, Flora Zagouri

Article2006

Biweekly gemcitabine and cisplatin in platinum-resistant/refractory, paclitaxel-pretreated, ovarian and peritoneal carcinoma

George Bozas, Aristotle Bamias, Vassiliki Koutsoukou, Eleni Efstathiou, Dimitra Gika, Christos Papadimitriou, Meletios A Dimopoulos

Article1999

Docetaxel-vinorelbine combination for platinum resistant paclitaxel pretreated ovarian cancer. A hellenic co-operative oncology group phase II study

Gerasimos Aravantinos, Dimitrios Bafaloukos, Meletios A Dimopoulos, C. Nikolaides, Pavlos Papakostas, Christos Kiamouris, K. Sikiotis, T. Rapsomaniki, George Fountzilas, D. Skarlos